Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications
Sponsor: Sucampo Pharmaceuticals, Inc.
Terminated
Number of needed participants could not be obtained
Other terminated trials from Sucampo Pharmaceuticals, Inc.
More terminations from Sucampo Pharmaceuticals, Inc.
This PHASE4 trial investigates Constipation and is currently terminated or withdrawn. Sucampo Pharmaceuticals, Inc. leads this study, which shows 11 recorded versions since 2010 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Oct 2020 — Dec 2020 [monthly]
Terminated PHASE4
Status: Completed → Terminated
-
Jun 2018 — Oct 2020 [monthly]
Completed PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sucampo Pharmaceuticals, Inc.
- Takeda
- University of South Alabama
For direct contact, visit the study record on ClinicalTrials.gov .